{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:14:45Z","timestamp":1770498885800,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.09.011","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T15:18:44Z","timestamp":1158679124000},"page":"2420-2427","source":"Crossref","is-referenced-by-count":38,"title":["Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel J","family":"Isaacman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Fritzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ciuryla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Schranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.09.011_bib1","series-title":"\u201cCommunity Immunity\u201d. Vaccines","first-page":"1443","author":"Fine","year":"2004"},{"key":"10.1016\/j.vaccine.2006.09.011_bib2","unstructured":"Farr W. Second annual report of the registrar\u2014general of births, deaths, and marriages in England. Her Majesty's Stationery Office, London, 1840."},{"key":"10.1016\/j.vaccine.2006.09.011_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S0022172400031478","article-title":"The spread of bacterial infection: the problem of herd immunity","volume":"21","author":"Topley","year":"1923","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2006.09.011_bib4","series-title":"Epidemics and Crowd Diseases","author":"Greenwood","year":"1935"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.011_bib5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/ije\/23.6.1300","article-title":"Epidemiology of pertussis in Denmark: the impact of herd immunity","volume":"23","author":"Nielsen","year":"1994","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.09.011_bib6","first-page":"88","article-title":"Decline in Haemophilus influenzae type B invasive infections at five Canadian pediatric centres","volume":"19","author":"Scheifele","year":"1993","journal-title":"Can Commun Dis Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.011_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0264-410X(98)00165-0","article-title":"Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.011_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/314535","article-title":"Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia","volume":"179","author":"Peltola","year":"1999","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.011_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/adc.86.6.396","article-title":"The UK Hib vaccine experience","volume":"86","author":"Heath","year":"2002","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.vaccine.2006.09.011_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM200103223441204","article-title":"The Japanese experience with vaccinating schoolchildren against influenza","volume":"344","author":"Reichert","year":"2001","journal-title":"N Engl J Med"},{"issue":"9431","key":"10.1016\/j.vaccine.2006.09.011_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.011_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1099\/0022-1317-51-2-98","article-title":"The pneumococcus: carriage, disease and conjugate vaccines","volume":"51","author":"Obaro","year":"2002","journal-title":"J Med Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2006.09.011_bib13","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O\u2019Brien","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.011_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.011_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis","volume":"106","author":"Abramson","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.09.011_bib16","unstructured":"Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000;49(RR-9):1\u201335."},{"issue":"2 Pt 1","key":"10.1016\/j.vaccine.2006.09.011_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.106.2.367","article-title":"American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis","volume":"106","author":"Overturf","year":"2000","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2006.09.011_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.011_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings","volume":"22","author":"Givon-Lavi","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2006.09.011_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammit","year":"2006","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2006.09.011_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active bacterial core surveillance of the emerging infections program network. Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.09.011_bib22","unstructured":"Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent Pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003. MMWR Morb Mortal Wkly Rep 2005;54(36):893\u20137."},{"issue":"16","key":"10.1016\/j.vaccine.2006.09.011_bib23","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.vaccine.2006.09.011_bib24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.09.011_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.inf.0000133046.60555.de","article-title":"Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine","volume":"23","author":"Talbot","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"18","key":"10.1016\/j.vaccine.2006.09.011_bib26","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.291.18.2197","article-title":"Active bacterial core surveillance\/emerging infections program network. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections","volume":"291","author":"Flannery","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.011_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2006.09.011_bib28","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","article-title":"Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity","volume":"23","author":"Hennessy","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.011_bib29","doi-asserted-by":"crossref","unstructured":"Kellner JD, Church DL, MacDonald J, Tyrrell GJ, Scheifele D. Progress in the prevention of pneumococcal infection. CMAJ 2005;173(10):1149\u201351 [erratum in: CMAJ 2006;174(1):67].","DOI":"10.1503\/cmaj.051150"},{"key":"10.1016\/j.vaccine.2006.09.011_bib30","unstructured":"Tropical Public Health Unit. CDC newsletter. Invasive pneumococcal disease in indigenous children in North Queensland. November 2005;51:5\u20137."},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2006.09.011_bib31","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1016\/j.vaccine.2005.05.043","article-title":"Declining invasive pneumococcal disease in the U.S. elderly","volume":"23","author":"McBean","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.011_bib32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/498745","article-title":"Trends in invasive pneumococcal disease-associated hospitalizations","volume":"42","author":"Shah","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.011_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.inf.0000222403.42974.8b","article-title":"Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J."},{"issue":"11","key":"10.1016\/j.vaccine.2006.09.011_bib34","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.283.11.1460","article-title":"Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children","volume":"283","author":"Lieu","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.09.011_bib35","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.vaccine.2004.08.051","article-title":"Pneumococcal pneumonia in the UK\u2014how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)","volume":"23","author":"McIntosh","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.011_bib36","unstructured":"Health Council of the Netherlands. Vaccination of infants against pneumococcal infections. The Hague: Health Council of the Netherlands;2005 [publication no. 2005\/13]."},{"key":"10.1016\/j.vaccine.2006.09.011_bib37","unstructured":"Claes C, Reinert RR. Cost-effectiveness of PnC-7 in Germany including herd immunity. 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID):Valencia, Spain;May 18\u201320, 2005 [abstract presentation 378]."},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.011_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","article-title":"Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization","volume":"144","author":"Flannery","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T07:11:37Z","timestamp":1555830697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06010085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06010085"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}